JGASX
Price
$47.23
Change
+$0.01 (+0.02%)
Updated
Dec 3 closing price
Net Assets
23.69B
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

JGASX vs VIGRX

Header iconJGASX vs VIGRX Comparison
Open Charts JGASX vs VIGRXBanner chart's image
JPMorgan Growth Advantage I
Price$47.23
Change+$0.01 (+0.02%)
VolumeN/A
Net Assets23.69B
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
JGASX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
JGASX vs. VIGRX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JGASX is a Buy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. JGASX (23.7B). VIGRX pays higher dividends than JGASX: VIGRX (0.30) vs JGASX (0.00). JGASX was incepted earlier than VIGRX: JGASX (20 years) vs VIGRX (33 years). JGASX (0.83) is less costly to investors than VIGRX (0.17). JGASX is a more actively managed with annual turnover of: 36.00 vs. VIGRX (11.00). VIGRX has a lower initial minimum investment than JGASX: VIGRX (3000) vs JGASX (1000000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. JGASX (8.45). VIGRX return over 5 years is better than : 99.11 vs. JGASX (41.25).
JGASXVIGRXJGASX / VIGRX
Total Expense Ratio0.740.17435%
Annual Report Gross Expense Ratio0.830.17488%
Fund Existence20 years33 years-
Gain YTD17.19619.76487%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets23.7B357B7%
Annual Yield % from dividends0.000.30-
Returns for 1 year8.4518.4946%
Returns for 3 years86.53110.8278%
Returns for 5 years41.2599.1142%
Returns for 10 years192.09349.1355%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT